12,743,039 Shares of Common Stock Pre-Funded Warrants to Purchase 7,220,794 Shares of Common Stock Foghorn Therapeutics Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • May 22nd, 2024 • Foghorn Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 22nd, 2024 Company Industry Jurisdiction